About us

invoX Pharma was incorporated in March 2021 and is a wholly owned subsidiary of Sino Biopharm, a Hong Kong listed, global top 40 pharmaceutical company with more than 24,000 employees. UK-based invoX is an expanding biopharmaceutical company focusing on R&D, Clinical Development and Business Development activities in the UK, EU and US, with a core focus on oncology and respiratory therapeutics.

Our core team is made up of a multicultural international group of highly experienced individuals with life sciences and technology-centred backgrounds, all with a mutual passion and ambition for creating something different.


We aspire to improve people’s lives by creating access to innovative medicine.


To be a leading global pharmaceutical company through delivering innovative therapies for patients.


invoX’s mission by 2026 is to be a globally recognised, fully integrated pharmaceutical company with an advancing pipeline of innovative products addressing unmet healthcare needs.


Integrity:  We can be trusted and relied upon to consistently do the right thing

Quality:  We hold ourselves to the highest standards in everything we do

Passion:  We are passionate in our mission to deliver innovation

Performance:  As a team we consistently strive to achieve exceptional results

Well being:  We support our employees to achieve their goals in every aspect of their live


We are well on our way, through multiple acquisitions and investments, to create a scalable platform to build a portfolio of promising clinical and pre-clinical stage drug candidates, which we believe will improve people’s lives by creating access to innovative medicine across some of our key therapeutic areas including oncology and respiratory.

Our Team

With experience and expertise in the pharmaceutical industry, our team is dedicated and passionate about our work at invoX.

Meet our Team